23andMe Is Monetizing Your DNA the Way Facebook Monetizes 'Likes'
So on one side journalists lament lack of new drug development &amp; just the shoddy state of healthcare tech, while as soon as any new data that can potentially unlock new drug targets (23andMe) or provider better support (Google DeepMind Health) is introduced, Such efforts are quickly demonized with spread of Fear, Uncertainty and Doubt.<p>Rather than asking important questions such as at which level the &quot;aggregate&quot; data is shared, or what safeguards exists, the blog post and source &quot;Gizmodo&quot; article is quick to jump gun and spread fear (You are the product &#x2F; you are being sold!!!). These posts are targeted to derive same emotional response that drive anti-vaxxers &#x2F; anti-GMO nuts.